/viestories/media/media_files/2025/02/07/oEf3PJ0f8F3MH2uJpU7U.png)
Gennex Share Price Target
Gennex Laboratories has been manufacturing pharmaceutical ingredients since 1995, offering investors a strong portfolio with a variety of products for the healthcare industry.
Gennex Laboratories has its manufacturing unit located in IDA Bollaram, Telangana. This company's sector is currently trading below Rs 20 per share, with hopes to provide better opportunities for its investors in the future.
/viestories/media/media_files/2025/02/03/6xUSNufI4vmd02Dk19Tx.jpg)
In this article, we will present Gennex Share Price Target for 2025 and beyond, along with annual financial results. This will provide investors with a clear understanding of the potential of the share market.
Gennex Share Price Target 2025
Check out the Gennex share price target for 2025, with maximum projections ranging from ₹26.24 (January) to ₹35.90 (December) and minimum targets from ₹16.04 to ₹21.00. Stay updated on stock trends and future forecasts!
| Month (2025) | Maximum Target | MinimumTarget |
| January | Rs 26.24 | Rs 16.04 |
| February | Rs 26.58 | Rs 16.67 |
| March | Rs 27.00 | Rs 16.89 |
| April | Rs 27.67 | Rs 17.12 |
| May | Rs 28.26 | Rs 17.56 |
| June | Rs 29.80 | Rs 18.90 |
| July | Rs 30.36 | Rs 18.99 |
| August | Rs 31.09 | Rs 19.38 |
| September | Rs 31.32 | Rs 19.80 |
| October | Rs 33.06 | Rs 20.36 |
| November | Rs 34.79 | Rs 20.61 |
| December | Rs 35.90 | Rs 21.00 |
Know more about the best traders in India.
Gennex Share Price Target 2026 to 2030
Check out the Gennex share price target from 2026 to 2030, with maximum projections rising from ₹47.43 in 2026 to ₹84.82 in 2030 and minimum targets from ₹25.78 to ₹38.09. Stay updated on stock trends and future forecasts!
| Year | Maximum Target | Minimum Target |
|---|---|---|
| 2026 | Rs 47.43 | Rs 25.78 |
| 2027 | Rs 56.89 | Rs 29.34 |
| 2028 | Rs 65.09 | Rs 32.67 |
| 2029 | Rs 78.66 | Rs 35.89 |
| 2030 | Rs 84.82 | Rs 38.09 |
Gennex Lab LTD Competitors (Market Cap: 332.62 crores INR)
/viestories/media/media_files/2025/07/17/rising-india-1150x300-02_728x180-2025-07-15-15-37-07-2025-07-17-10-55-11.webp)
- Sun Pharma Market Cap: 353,410.04 cr INR
- CIPLA Market Cap: 119,469.67 cr INR
- Divis Lab Market Cap: 113,909.91 cr INR
- Zydus Life Market Cap: 107,038.14 cr INR
Conclusion - Gennex Share Price
Gennex Share Price History has remained mostly flat throughout its two decades trading journey on the Bombay Stock Exchange(BSE). Listed on the BOm as 531739 since 1999, it continues to trade as a penny stock in the share market. While early Investors may be disappointed with its slow growth, Overall, the last five year’s Gennex Share Price has provided more than 350% since June 2019.
FAQs
Disclaimer:
- The information is based on our understanding of the stock's historical performance.
- Stock market predictions are unpredictable and can change, so expert advice is strongly recommended before investing.
- The values provided are based on predictions and may not be accurate, we recommend verifying the information with other sources.
- For further inquiries about the stock market, please contact us via email.
